About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.
In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, ...
The neurons responsible for this process can each perform different tasks: for example, some mainly process motion, others lines or colors. In the 1960s, David Hubel and Torsten Wiesel famously ...
In the February 10 Nature Medicine, scientists led by Jorge Llibre-Guerra and Randall Bateman at Washington University, St.
Lifetime history of heavy cannabis use is associated with lower brain activation on working memory tasks among young adults.
Little is known about the associated brain activation during these sleep rhythms, and even less about their functional implications. In this study, we investigated the brain-wide activation underlying ...
The stimulated areas were PC, the area of interest, and the left posterior parietal cortex (l-PPC), considered as a control area. The order of the stimulation was counterbalanced across participants.
I terms of Regulation 30 read with Regulation 33 of SEBI (LODR) Regulations, 2015 attached are the Integrated Unaudited Financial Results for quarter and nine months ended 31.12.2024 along with LLR ...
Introduction Deficits in voluntary muscle activation and altered motor cortex function are present following serious knee injury and are proposed to influence rehabilitation outcomes. It is unknown if ...
While AI will not replace health care providers, it will change how medicine is practiced, emphasizing the need for human oversight and ethical considerations. This summary was automatically ...
Endovascular treatment (EVT) of stroke with large-vessel occlusion is known to be safe and effective. The effect of EVT for occlusion of medium or distal vessels is unclear. We randomly assigned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback